http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9321860-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b2aa951bf0c15535a4552ee779bb8bd8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L33-0017
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L33-00
filingDate 1993-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94fbdeb7ef9f593fbd51031a489ff484
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c206e6be6e3a4081070efcfc83bf6483
publicationDate 1993-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-9321860-A1
titleOfInvention Non-thrombogenic vascular prosthesis
abstract The invention provides vascular prostheses (10) free of any substance that counteracts an anti-coagulant comprising a base material having inner (16) and outer (14) surfaces, wherein the outer surface has a layer of a material capable of reducing the porosity of said prosthesis to blood or body fluid and a coating of compounded heparin (24) bound thereon, and the inner surface (16) has a coating of compounded heparin (24) bound thereon, the compounded heparin (24) comprising heparin and a cationic surfactant. The present invention also provides a method for forming a vascular prosthesis. The vascular prostheses (10) exhibit an initial low porosity thereby obviating the need for pre-clotting the prosthesis. The compounded heparin (24) coating of the vascular prostheses prevents or slows down blood clotting which leads to the build up of natural tissue within the interstitial spaces of the prosthesis (10) and the build-up of a thin, even, well-defined and well-adhered pseudo-intima on the inner surface of the prosthesis (10).
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6071306-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5693085-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2298577-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9938547-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9938547-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021257674-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0878173-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2298577-A
priorityDate 1992-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8800813-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4879135-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4822361-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3425418-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4321711-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57199466
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4763
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8753
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226574640
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402238
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22603866
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID81601
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393816
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6610295
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226573509
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226439681
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400544
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID636402
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406750

Total number of triples: 43.